The aim of this study was to determine the effect of chromium (Cr)-enriched yeast on blood glucose and insulin variables, blood lipids, and blood markers of oxidative stress in persons with type 2 diabetes mellitus (median duration: 3.0 yr). Thirty-six subjects (9 men, 27 women; mean age: 61.3 yr; mean body mass index: 34.33 kg/m2) were supplemented with 400 μg Cr/d as Cr-enriched yeast (n=19) or placebo (n=17) for 12 wk in a randomized, double-blind study. The most interesting results were obtained by comparison of the change in the placebo group to the change in the Cr group. The Cr group showed a significantly greater increase in serum Cr compared to the placebo group (p<0.05). Supplementation with Cr-enriched yeast was associated with a significant decrease in fasting serum glucose compared to placebo (p<0.01). Blood markers of oxidative stress glutathione peroxidase activity and levels of reduced glutathione were essentially unchanged in the Cr group after 12 wk, but decreased significantly in the placebo group (p<0.05, p<0.01, respectively), Serum HbA1c and glycated protein (fructosamine) were essentially unchanged in the Cr group, whereas HbA1c tended to increase in the placebo group (from 6.94% to 7.11%). Fasting serum insulin decreased in both groups, with a greater tendency in the Cr group (−16.5% vs −9.5%). These data suggest that supplementation of well-controlled type 2 diabetics with Cr-enriched yeast is safe and can result in improvements in blood glucose variables and oxidative stress.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
K. Schwarz and W. Mertz, Chromium (III) and the glucose tolerance factor, Arch. Biochem. Biophys. 85, 292–295 (1959).
I. W. Davidson and W. L. Blackwell, Changes in carbohydrate metabolism of squirrel monkeys with Chromium dietary supplementation, Proc. Soc. Exp. Biol. Med. 127, 66–70 (1968).
K. N. Jeejeebhoy, R. C. Chu, E. B. Marliss, G. R. Greenberg, and A. Bruce-Robertson, Chromium deficiency, glucose intolerance, and neuropathy reversed by Chromium supplementation, in a patient receiving long-term total parenteral nutrition, Am. J. Clin. Nutr. 30, 531–538 (1977).
R. A. Anderson, N. Cheng, N. A. Bryden, et al., Elevated intakes of supplemental Chromium improve glucose and insulin variables in individuals with type 2 diabetes, Diabetes 46, 1786–1791 (1997).
C. M. Davis and J. B. Vincent, Chromium oligopeptide activates insulin receptor tyrosine kinase activity, Biochemistry 36, 4382–4385 (1997).
J. B. Vincent Elucidating a biological role for Chromium at a molecular level, Acc. Chem. Res. 33, 503–510 (2000).
J. B. Vincent, Recent advances in the nutritional biochemistry of trivalent Chromium, Proc. Nutr. Soc. 63, 41–47 (2004).
J. B. Vincent, Recent developments in the biochemistry of Chromium(III), Biol. Trace Element Res. 99, 1–16 (2004).
M. H. Mendler, B. Turlin, R. Moirand, et al., Insulin resistance-associated hepatic iron overload, Gastroenterology, 117, 1155–1163 (1999).
W. Ding, Z. Chai, P. Duan, W. Feng, and Q. Qian, Serum and urine Cr concentrations in elderly diabetics, Biol. Trace Element Res. 63, 231–237 (1998).
B. W. Morris, S. MacNeil, C. A. Hardisty, S. Heller, C. Burgin, and T. A. Gray, Chromium homeostasis in patients with type II (NIDDM) diabetes, J. Trace Elements Med. Biol. 13, 57–61 (1999).
G. J. Ryan, N. S. Wanko, A. R. Redman, and C. B. Cook, Chromium as adjunctive treatment for type 2 diabetes, Ann. Pharmacother. 37, 876–885 (2003).
S. M. Bahijiri, S. A. Mira, A. M. Mufti, and M. A. Ajabnoor, The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes, Saudi Med. J. 21, 831–837 (2000).
M. I. Uusitupa, L. Mykkanen, O. Siitonen, et al., Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels, Br. J. Nutr. 68, 209–216 (1992).
N. A. Lee and C. A. Reasner, Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM, Diabetes Care 17, 1449–1452 (1994).
R. A. Anderson, A. M. Roussel, N. Zouari, S. Mahjoub, J. M. Matheau, and A. Kerkeni, Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus, J. Am. Coll. Nutr. 20, 212–218 (2001).
E. G. Offenbacher and F. X. Pi-Sunyer, Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects, Diabetes 29, 919–925 (1980).
R. T. Mossop, Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics, Central Afr. J. Med. 29, 80–82 (1983).
C. D. Hunt and B. J. Stoecker, Deliberations and evaluations of the approaches, endpoints and paradigms for boron, chromium and fluoride dietary recommendations, J. Nutr. 126, 2441S-2451S (1996).
M. D. Althuis, N. E. Jordan, E. A. Ludington, and J. T. Wittes, Glucose and insulin responses to dietary chromium supplements: a meta-analysis, Am. J. Clin. Nutr. 76, 148–155 (2002).
J. K. Speetjens, R. A. Collins, J. B. Vincent, and S. A. Woski, The nutritional supplement chromium (III) tris(picolinate) cleaves DNA, Chem. Res. Toxicol 12, 483–487 (1999).
N. F. Wiernsperger, Oxidative stress: the special case of diabetes, Biofactors 19, 11–18 (2003).
D. Giugliano, A. Ceriello, and G. Paolisso, Oxidative stress and diabetic vascular complications, Diabetes Care 19, 257–267 (1996).
A. M. Jentzsch, H. Bachmann, P. Furst, and H. K. Biesalski, Improved analysis of malondialdehyde in human body fluids, Free Radical Biol. Med. 20, 251–256 (1996).
P. Chappuis, J. Poupon, J. F. Deschamps, P. J. Guillausseau, and F. Rousselet, Physiological chromium determination in serum by Zeeman graphite furnace atomic absorption spectrometry. A serious challenge, Biol. Trace Element Res. 32, 85–91 (1992).
B. D. Milne, Trace elements, in Tietz Fundamentals of Clinical Chemistry C. Burtis and E. Ashwood, eds., W. B. Saunders, Philadelphia, pp. 568–583 (2001).
N. Cheng, X. Zhu, H. Shi, et al., Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium, J. Trace Elements Exp. Med. 12, 55–60 (1999).
S. M. A. Bahijri and A. M. B. Mufti, Beneficial effects of chromium in people with type 2 diabetes, and urinary chromium response to glucose load as a possible indicator of status, Biol. Trace Element Res. 85, 97–109 (2002).
M. Rukgauer and A. Zeyfang, Chromium determinations in blood cells: clinical relevance demonstrated in patients with diabetes mellitus type 2, Biol. Trace Element Res. 86, 193–202 (2002).
A. S. Kozlovsky, P. B. Moser, S. Reiser, and R. A. Anderson, Effects of diets high in simple sugars on urinary chromium losses, Metabolism 35, 515–518 (1986).
N. Cheng, X. Zhu, H. Shi, W. Wu, J. Chi, and J. Cheng, R. Anderson, Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium, Biol. Trace Elements Exp. Med. 12, 55–60 (1999).
R. Riales and M. J. Albrink, Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men, Am. J. Clin. Nutr. 34, 2670–2678 (1981).
V. L. Thomas and S. S. Gropper, Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors, Biol. Trace Element Res. 55, 297–305 (1996).
L. G. Trow, J. Lewis, R. H. Greenwood, et al., Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes, Int. J. Vitam. Nutr. Res. 70, 14–18 (2000).
H. Cheng, M. Lai, W. Hou, and C. Huang, Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects, J. Agric. Food Chem. 52, 1385–1389 (2004).
About this article
Cite this article
Racek, J., Trefil, L., Rajdl, D. et al. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol Trace Elem Res 109, 215–230 (2006). https://doi.org/10.1385/BTER:109:3:215
- diabetes mellitus
- glycated hemoglobin
- oxidative stress